News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 29, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Majority of Surveyed Gastroenterologists Have a Positive Reaction to Takeda's Cell Adhesion Molecule Inhibitor Entyvio

 Decision Resources Group finds that one month post-launch, the majority of surveyed gastroenterologists are aware and familiar with Entyvio as...

Sep 25, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Pharmas Are Leaving Healthcare Professionals Hanging in a Mature Mobile Market, Manhattan Research Study Finds

 Pharmas are failing to mobile optimize their websites for healthcare professionals, even as mobile devices, and particularly smartphones, have...

Sep 25, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

While Physicians are Receptive to Emerging Antibiotics For Drug-Resistant Gram-Negative Infections, Payers Expect to Limit Hospital Use of Novel Premium-Priced Agents

Decision Resources Group finds that the majority of surveyed infectious diseases (ID) specialists and internists are willing to prescribe Actavis/...

Sep 23, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach

 Decision Resources Group finds that similarities in pricing and reimbursement (P&R) decision criteria and payer requirements in key...

Sep 23, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The U.S. Surgical Navigation System Market Will Expand to $260 Million By 2023

Decision Resources Group finds that the United States market for surgical navigation systems will gradually expand due to demand for minimally...

Sep 22, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry

Decision Resources Group finds that by the end of 2014, the Chilean pharmaceutical market is expected to be worth $2 billion (U.S. dollars),...

Sep 18, 2014, 11:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients

 Decision Resources Group finds that at one year post-launch in the United States, 54 percent of surveyed U.S. medical oncologists have...

Sep 18, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD

 Decision Resources Group finds that Regeneron's Eylea, the most recently launched anti-vascular endothelial growth factor (VEGF) agent for wet...

Sep 17, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm

 Decision Resources Group finds that among Crohn's disease/ulcerative colitis (CD/UC) patients eligible for biologic therapy, only a proportion...

Sep 17, 2014, 12:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Continued Uptake of Branded Therapies Will Drive the Type 2 Diabetes Market to Increase from $26 Billion in 2013 to $47 Billion in 2023

 Decision Resources Group finds that as physicians continue to adopt a more individualized approach to patient care, branded type 2 diabetes...

Sep 16, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

While the Overall Use of Rheumatoid Arthritis Biologics Remains Stable in the Major European Markets, Newer Agents are Gaining Momentum over More Mature Products

 Decision Resources Group finds that the percentage of rheumatoid arthritis (RA) patients treated with a biologic agent by rheumatologists has...

Sep 16, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics

 Decision Resources Group finds that the rheumatoid arthritis (RA) disease-modifying antirheumatic drug market will increase from $14 billion...

Sep 15, 2014, 13:33 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Physician device decision-makers show strong demand for device manufacturer digital content and support

 Decision Resources Group's new Manhattan Research study, Digital MedTech Physician™ 2014, finds that online information and other...

Sep 15, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents

 Decision Resources Group finds that as the type 2 diabetes treatment armamentarium continues to expand, increasing pressure to control...

Sep 10, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Expected Launch of First Disease-Modifying Therapies Through 2023 Will Revolutionize Treatment of Duchenne Muscular Dystrophy

 Decision Resources Group finds that the first three emerging disease-modifying therapies (DMTs)—PTC Therapeutics' Translarna...

Sep 10, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Merck & Co.'s Keytruda is Approved in the United States for the Treatment of Advanced and Unresectable Malignant Melanoma

 The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a...

Sep 09, 2014, 13:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Advantages Over Traditional Therapies Will Drive Strong Expansion in the U.S. Interventional Oncology Device Market

Decision Resources Group finds that the United States interventional oncology device market will see strong growth, reaching a value of $760...

Sep 08, 2014, 13:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Coloplast and ConvaTec Gain New Patient Capture in the U.S. Ostomy Market

 Decision Resources Group finds that major market players, driven by new technology, will continue to jostle for the greatest product share in...

Sep 08, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Phoenix, Tucson Health System Mergers Reshape Arizona Market

 Decision Resources Group finds that two planned mergers between health system in Phoenix and Tucson could lead to greater competition and...

Sep 08, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Rising Awareness of Dental Implant Treatments Will Drive Strong Procedure Volume Growth in Latin America

 Decision Resources Group finds that dental procedure volumes will see strong expansion as the population ages and as awareness of these...